首页> 外文期刊>Laboratory investigation >Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2
【24h】

Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2

机译:结直肠癌中多重荧光IHC的数字图像分析认识到CDX2的预后值及其与SOX2的负相关性

获取原文
获取外文期刊封面目录资料

摘要

Flourescence-based multiplex immunohistochemistry (mIHC) combined with multispectral imaging and digital image analysis (DIA) is a quantitative high-resolution method for determination of protein expression in tissue. We applied this method for five biomarkers (CDX2, SOX2, SOX9, E-cadherin, and -catenin) using tissue microarrays of a Norwegian unselected series of primary colorectal cancer. The data were compared with previously obtained chromogenic IHC data of the same tissue cores, visually assessed by the Allred method. We found comparable results between the methods, although confirmed that DIA offered improved resolution to differentiate cases with high and low protein expression. However, we experienced inherent challenges with digital image analysis of membrane staining, which was better assessed visually. DIA and mIHC enabled quantitative analysis of biomarker coexpression on the same tissue section at the single-cell level, revealing a strong negative correlation between the differentiation markers CDX2 and SOX2. Both methods confirmed known prognostic associations for CDX2, but DIA improved data visualization and detection of clinicopathological and biological associations. In summary, mIHC combined with DIA is an efficient and reliable method to evaluate protein expression in tissue, here shown to recapitulate and improve detection of known clinicopathological and survival associations for the emerging biomarker CDX2, and is therefore a candidate approach to standardize CDX2 detection in pathology laboratories. Digital image analysis (DIA) of multiplex fluorescence-based immunohistochemistry and visual chromogenic evaluation of CDX2, SOX2, SOX9, E-cadherin, and -catenin in colorectal cancer are comparable, recognizing prognostic value of CDX2 and negative correlation with SOX2. Membrane staining is best evaluated visually, while DIA enables single-cell coexpression analysis and improves visualization and detection of clinicopathological and biological associations.
机译:基于荧光的多重免疫组织化学(MIHC)与多光谱成像和数字图像分析(DIA)是一种定量高分辨率方法,用于测定组织中蛋白质表达的定量高分辨率方法。我们使用挪威未选择系列的原发性结肠直肠癌的组织微阵列应用该方法对五种生物标志物(CDX2,Sox2,Sox9,E-Cadherin和-Catenin)。将数据与先前获得的相同组织核的发色性IHC数据进行比较,通过该方法目视评估。我们在方法之间发现了可比的结果,尽管确认DIA提出了改进的分辨率以区分高低蛋白质表达的情况。然而,我们经历了具有膜染色的数字图像分析的固有挑战,这在视觉上更好地评估。 DIA和MIHC能够在单细胞水平的同一组织截面上使生物标志物共表达的定量分析,揭示了分化标志物CDX2和SOX2之间的强负相关。两种方法证实了已知的CDX2预后关联,但DIA改善了数据可视化和临床病理学和生物学协会的检测。总之,MIHC与DIA结合是一种有效且可靠的方法,可评估组织中的蛋白质表达,其目前表明是重新携带和改善新出现的生物标志物CDX2的已知临床病理和存活缔合的检测,因此是标准化CDX2检测的候选方法病理实验室。 CDX2,Sox2,Sox9,E-Cadherin的多重荧光免疫组织化学和视觉发色评价的数字图像分析(Dia)和结直肠癌中的-Catenin是可比的,识别CDX2的预后值和与SOX2的负相关性。膜染色是最佳的视觉评估,而DIA使单细胞共表达分析能够改善临床病理和生物学关联的可视化和检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号